Skip to main content

Loading market data...

EW

Edwards Lifesciences Corporation

NYSE • United states

$88.29

+$1.07

(+1.23%)

Source: Yahoo Finance · Quote time Oct 20, 2026 20:00 GMT+0000

Catalyst Evidence

No verified catalyst stored yet

Click “View” to see the stored chain of evidence (if available).

Management
Credibility
Score

Edwards Lifesciences Corporation (EW)

Unavailable

Quotes may be delayed

$50.89B

Market Cap

1,795,549

Volume

50.6

P/E Ratio

Unavailable

Div Yield

Edwards Lifesciences Corporation Price Chart

Loading price history…

Management Credibility Analysis

Unavailable

Verified Management Score Unavailable

Management credibility requires sourced guidance and earnings history.

Upcoming Catalysts

Verified event feed

Verified Catalysts Unavailable

No sourced upcoming event feed is configured for this stock yet.

Company profile

No description available

Chief executive: Not disclosed
Headquarters: ONE EDWARDS WAY, IRVINE, CA
Founded: Not disclosed

📈 Company Timeline

Major business events

Positive

Negative

Neutral

29 Aug 2026

Edwards Lifesciences Corporation reported A director or senior management change or compensation event

Edwards Lifesciences Corporation filed an 8-K covering a director or senior management change or compensation event.

5 Aug 2026

Edwards Lifesciences Corporation securities registration filing

Edwards Lifesciences Corporation filed a registration or prospectus document concerning securities.

5 Aug 2026

Edwards Lifesciences Corporation filed Form 10-Q

Edwards Lifesciences Corporation submitted Form 10-Q to the SEC for the period ending Jun 30, 2026.

24 Jul 2026

Edwards Lifesciences Corporation reported Operating or financial results

Edwards Lifesciences Corporation filed an 8-K covering operating or financial results, supporting financial statements or exhibits.

9 May 2026

Edwards Lifesciences Corporation reported A director or senior management change or compensation event

Edwards Lifesciences Corporation filed an 8-K covering a director or senior management change or compensation event, shareholder voting results, supporting financial statements or exhibits.

Capital Structure & Financial Position

Financial strength and liquidity analysis

Cash and equivalents (USD)$2.91B

Total assets (USD)$13.87B

Total liabilities (USD)$3.14B

Shareholders' equity (USD)$10.62B

Long-term debt (USD)$598.70M

Debt due within a year (USD)$0

Source: SEC EDGAR company facts (opens in a new tab) Balance sheet dated 30 Jun 2026

Peer Comparison - Health Care

Company	Price	Market Cap
LLY - Eli Lilly and Company	$1,276.13 Yahoo Finance	$1.20T
JNJ - Johnson & Johnson	$256.74 Yahoo Finance	$618.71B
ABBV - AbbVie Inc.	$284.80 Yahoo Finance	$503.28B
UNH - UnitedHealth Group Incorporated	$418.43 Yahoo Finance	$375.58B
MRK - Merck & Co., Inc.	$148.55 Yahoo Finance	$366.50B

📋 Corporate Actions

Recent and upcoming corporate events

Verified Corporate Actions Unavailable

Dividend, buyback, split, and spin-off feeds are not ingested for this stock yet.

Financials

Financial statements and key metrics analysis

Quarter	Revenue (USD)	Operating income	Net income	Diluted EPS (USD)	Filed
Q2 2026	$1.74B	$513.20M	$241.90M	$0.42	10-Q · 4 Aug 2026
Q1 2026	$1.65B	$477.60M	$380.70M	$0.66	10-Q · 6 May 2026
Q4 2025	$1.57B	$151.10M	$91.20M	Unavailable	10-K · 25 Feb 2026
Q3 2025	$1.55B	$307.10M	$291.10M	$0.50	10-Q · 5 Nov 2025
Q2 2025	$1.53B	$411.20M	$333.20M	$0.56	10-Q · 6 Aug 2025
Q1 2025	$1.41B	$394.80M	$358.00M	$0.61	10-Q · 6 May 2025

Source: SEC EDGAR company facts (opens in a new tab)

Analyst Consensus

Buy

Target: $104.31

18.1% upside potential

📈

Strong Buy

Unavailable

👍

Buy

12

⏸️

Hold

3

📉

Sell

0

15 analysts covering this stock

Source: Nasdaq analyst research (opens in a new tab) Retrieved 21 Oct 2026, 06:47 UTC Targets range 85.00–110.00 Ratings are third-party opinions, not advice.

💰 Upcoming Dividends

Next dividend payments

Verified Dividend Data Unavailable

Dividend calendar data is not ingested for this stock yet.

Guidance Evolution

Verified Guidance History Unavailable

Verified company guidance history is not ingested for this stock yet.

💼 Director Transactions

Recent insider activity

8

Oct 2026

Lippis Daniel J.

CVP, TAVR

Option exercise

$72.68 per share

619 shares

8

Oct 2026

Lippis Daniel J.

CVP, TAVR

Open-market sale

$85.65 per share

619 shares

14

Sep 2026

Markowitz Wayne

CVP, JAPAC

Tax withholding

$84.37 per share

568 shares

13

Sep 2026

Dahl Andrew M.

SVP, Corporate Controller

Tax withholding

$84.37 per share

253 shares

11

Sep 2026

Markowitz Wayne

CVP, JAPAC

Tax withholding

$86.77 per share

355 shares

11

Sep 2026

Chopra Daveen

CVP, TMTT, Surgical & IHFM

Tax withholding

$86.77 per share

398 shares

11

Sep 2026

Lippis Daniel J.

CVP, TAVR

Option exercise

$72.68 per share

619 shares

11

Sep 2026

Lippis Daniel J.

CVP, TAVR

Open-market sale

$87.51 per share

619 shares

31

Aug 2026

Dahl Andrew M.

SVP, Corporate Controller

Open-market sale

$91.06 per share

544 shares

28

Aug 2026

Bruls Annette

CVP, EMEACLA

Open-market sale

$89.98 per share

2,644 shares

Top Shareholders

Vanguard Group Inc

70,079,435 shares

-0.403% change

12/31/2025

Blackrock, Inc.

58,789,433 shares

11.786% change

6/30/2026

Vanguard Capital Management Llc

37,615,952 shares

-0.296% change

6/30/2026

Vanguard Portfolio Management Llc

26,411,402 shares

0.017% change

6/30/2026

State Street Corp

26,321,940 shares

0.097% change

6/30/2026

Jpmorgan Chase & Co

22,783,175 shares

4.776% change

6/30/2026

Wellington Management Group Llp

16,827,967 shares

-23.548% change

6/30/2026

Geode Capital Management, Llc

15,437,251 shares

17.539% change

6/30/2026

Bank Of New York Mellon Corp

14,084,483 shares

-15.851% change

6/30/2026

Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt

13,002,965 shares

1.491% change

6/30/2026

Source: Nasdaq institutional holdings (opens in a new tab) Observed 21 Oct 2026, 06:47 UTC· 1 day ago

Research coverage and investment tools

Edwards Lifesciences Corporation (EW) is a stock listed on the New York Stock Exchange in the United States, in the Health Care sector (Industrial Specialties). Its last price was US$88.29 on 20 Oct 2026. That is 63% of the way from its 52-week low of US$74.66 to its 52-week high of US$96.29. Its market capitalisation was US$50.89 billion at that price.

Watch Add to portfolio Set an alert Compare Position size

How position sizing works Dividend yield and total return

Quarter	Revenue	Operating income	Net income	Diluted EPS	Gross margin	Operating margin	Free cash flow	Filed
Q2 2026	$1.74B	$513.20M	$241.90M	$0.42	77.5%	29.5%	$585.00M	10-Q · 4 Aug 2026 (opens in a new tab)
Q1 2026	$1.65B	$477.60M	$380.70M	$0.66	78.0%	29.0%	−$21.10M	10-Q · 6 May 2026 (opens in a new tab)
Q4 2025	$1.57B	$151.10M	$91.20M	Unavailable	78.1%	9.6%	$353.50M	10-K · 25 Feb 2026 (opens in a new tab)
Q3 2025	$1.55B	$307.10M	$291.10M	$0.50	77.8%	19.8%	$516.20M	10-Q · 5 Nov 2025 (opens in a new tab)
Q2 2025	$1.53B	$411.20M	$333.20M	$0.56	77.5%	26.8%	$240.90M	10-Q · 6 Aug 2025 (opens in a new tab)
Q1 2025	$1.41B	$394.80M	$358.00M	$0.61	78.7%	27.9%	$224.40M	10-Q · 6 May 2025 (opens in a new tab)

Cash and equivalents: $2.91B
Total assets: $13.87B
Total liabilities: $3.14B
Shareholders' equity: $10.62B
Long-term debt: $598.70M
Debt due within a year: $0

8-K · 29 Aug 2026 · Management change

Edwards Lifesciences Corporation reported A director or senior management change or compensation event (opens in a new tab)

Edwards Lifesciences Corporation filed an 8-K covering a director or senior management change or compensation event.
S-8 · 5 Aug 2026

Edwards Lifesciences Corporation securities registration filing (opens in a new tab)

Edwards Lifesciences Corporation filed a registration or prospectus document concerning securities.
10-Q · 5 Aug 2026

Edwards Lifesciences Corporation filed Form 10-Q (opens in a new tab)

Edwards Lifesciences Corporation submitted Form 10-Q to the SEC for the period ending Jun 30, 2026.
8-K · 24 Jul 2026

Edwards Lifesciences Corporation reported Operating or financial results (opens in a new tab)

Edwards Lifesciences Corporation filed an 8-K covering operating or financial results, supporting financial statements or exhibits.
8-K · 9 May 2026 · Management change

Edwards Lifesciences Corporation reported A director or senior management change or compensation event (opens in a new tab)

Edwards Lifesciences Corporation filed an 8-K covering a director or senior management change or compensation event, shareholder voting results, supporting financial statements or exhibits.

Insider	Date	Transaction	Shares	Average price	Filing
Lippis Daniel J. CVP, TAVR	8 Oct 2026	Option exercise (M)	+619	$72.68	Form 4 (opens in a new tab)
Lippis Daniel J. CVP, TAVR	8 Oct 2026	Open-market sale (S)	−619	$85.65	Form 4 (opens in a new tab)
Markowitz Wayne CVP, JAPAC	14 Sep 2026	Tax withholding (F)	−568	$84.37	Form 4 (opens in a new tab)
Dahl Andrew M. SVP, Corporate Controller	13 Sep 2026	Tax withholding (F)	−253	$84.37	Form 4 (opens in a new tab)
Markowitz Wayne CVP, JAPAC	11 Sep 2026	Tax withholding (F)	−355	$86.77	Form 4 (opens in a new tab)
Chopra Daveen CVP, TMTT, Surgical & IHFM	11 Sep 2026	Tax withholding (F)	−398	$86.77	Form 4 (opens in a new tab)
Lippis Daniel J. CVP, TAVR	11 Sep 2026	Option exercise (M)	+619	$72.68	Form 4 (opens in a new tab)
Lippis Daniel J. CVP, TAVR	11 Sep 2026	Open-market sale (S)	−619	$87.51	Form 4 (opens in a new tab)
Dahl Andrew M. SVP, Corporate Controller	31 Aug 2026	Open-market sale (S)	−544	$91.06	Form 4 (opens in a new tab)
Bruls Annette CVP, EMEACLA	28 Aug 2026	Open-market sale (S)	−2,644	$89.98	Form 4 (opens in a new tab)

Institution	Report date	Shares	Change
Vanguard Group Inc	12/31/2025	70,079,435	-0.403%
Blackrock, Inc.	6/30/2026	58,789,433	11.786%
Vanguard Capital Management Llc	6/30/2026	37,615,952	-0.296%
Vanguard Portfolio Management Llc	6/30/2026	26,411,402	0.017%
State Street Corp	6/30/2026	26,321,940	0.097%
Jpmorgan Chase & Co	6/30/2026	22,783,175	4.776%
Wellington Management Group Llp	6/30/2026	16,827,967	-23.548%
Geode Capital Management, Llc	6/30/2026	15,437,251	17.539%
Bank Of New York Mellon Corp	6/30/2026	14,084,483	-15.851%
Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt	6/30/2026	13,002,965	1.491%

Previous close: 87.22 USD
Day range: 87.16 – 88.34 USD
52-week range: 74.66 – 96.29 USD
Volume: 1,795,549
Market cap: $50.89B
Average volume: 2,718,227
P/E ratio: 50.6
EPS (FY 2025, diluted): 1.83 USD
Shares outstanding: 576.40M
Beta (5Y monthly): 0.85

Price, ranges and volume: Yahoo Finance (opens in a new tab) Observed 20 Oct 2026, 20:00 UTC· 1 day ago

Average volume and shares: Nasdaq (opens in a new tab) Observed 22 Oct 2026, 06:09 UTC· 1 hour ago

P/E is market cap ÷ trailing 12-month net income from SEC filings.

EPS: SEC EDGAR company facts (opens in a new tab)

Beta: 5 years of monthly returns against the S&P 500, calculated from Yahoo Finance prices. Market cap is the price × shares outstanding.

This research is not available for EW yet

Guidance history

IMPORTANT FINANCIAL DISCLAIMER: The information provided on this platform is for educational and informational purposes only and should not be construed as investment advice. All investments involve risk, including potential loss of principal. Past performance does not guarantee future results. Take Profits is not a registered investment advisor and does not provide personalized investment advice. Users should conduct their own research and consult with qualified financial professionals before making investment decisions. Market data may be delayed and is provided by third-party sources.